These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3825895)

  • 21. [Tachycardia and ventricular fibrillation in the arrhythmogenic right ventricle (arrhythmogenic dysplasia of the right ventricle). Clinical and electrocardiographic spectrum].
    Nava A; Canciani B; Scognamiglio R; Buja GF; Daliento L; Miraglia G; Martini B; Thiene G
    G Ital Cardiol; 1986 Sep; 16(9):741-9. PubMed ID: 3803796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous sustained ventricular tachyarrhythmias during treatment with type IA antiarrhythmic agents.
    Kudenchuk PJ; Kron J; Walance C; McAnulty JH
    Am J Cardiol; 1990 Feb; 65(7):446-52. PubMed ID: 2305683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and results of electrophysiologic testing in young adults with ventricular tachycardia or ventricular fibrillation.
    Morady F; Scheinman MM; Hess DS; Chen R; Stanger P
    Am Heart J; 1983 Dec; 106(6):1306-14. PubMed ID: 6650352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signal-averaged electrocardiographic late potentials in patients with ventricular fibrillation or ventricular tachycardia: correlation with clinical arrhythmia and electrophysiologic study.
    Freedman RA; Gillis AM; Keren A; Soderholm-Difatte V; Mason JW
    Am J Cardiol; 1985 May; 55(11):1350-3. PubMed ID: 3993568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Myocardial lactate extraction during programmed ventricular stimulation and its value for etiologically-related therapy of ischemic ventricular tachyarrhythmia].
    Vester EG; Perings C; Kuhls S; Ochiulet-Vester J; Strauer BE
    Z Kardiol; 1995 Jun; 84(6):443-58. PubMed ID: 7653084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of clinical ventricular tachycardia using programmed stimulation: value of third and fourth extrastimuli.
    Mann DE; Luck JC; Griffin JC; Herre JM; Limacher MC; Magro SA; Robertson NW; Wyndham CR
    Am J Cardiol; 1983 Sep; 52(5):501-6. PubMed ID: 6613871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of electrical pacemakers in the treatment of ventricular tachycardia and ventricular fibrillation.
    Kerr CR; Klein GJ; Cooper JA; Sharma AD
    Cardiovasc Clin; 1985; 16(1):215-37. PubMed ID: 3915712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does the induction of ventricular flutter or fibrillation at electrophysiologic testing after myocardial infarction have any prognostic significance?
    Bourke JP; Richards DA; Ross DL; McGuire MA; Uther JB
    Am J Cardiol; 1995 Mar; 75(7):431-5. PubMed ID: 7863984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daily reproducibility of electrophysiologic test results in malignant ventricular arrhythmia.
    Lombardi F; Stein J; Podrid PJ; Graboys TB; Lown B
    Am J Cardiol; 1986 Jan; 57(1):96-101. PubMed ID: 3942083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A model of chronic ischemic arrhythmias: the relation between electrically inducible ventricular tachycardia, ventricular fibrillation threshold and myocardial infarct size.
    Gang ES; Bigger JT; Livelli FD
    Am J Cardiol; 1982 Sep; 50(3):469-77. PubMed ID: 7113930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ventricular arrhythmias: medical therapy, device treatment, and indications for electrophysiologic study.
    Sager PT; Batsford WP
    Cardiol Clin; 1988 Feb; 6(1):37-47. PubMed ID: 3048673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Facilitation of ventricular tachycardia induction with abrupt changes in ventricular cycle length.
    Denker S; Lehmann M; Mahmud R; Gilbert C; Akhtar M
    Am J Cardiol; 1984 Feb; 53(4):508-15. PubMed ID: 6198893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia.
    Wyndham CR; Pratt CM; Mann DE; Winkle RA; Somberg J; de Maria AN; Josephson ME
    Am J Cardiol; 1987 Oct; 60(11):67F-72F. PubMed ID: 3310588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sinus rhythm mapping in healed experimental myocardial infarction: contrasting activation patterns for inducing ventricular tachycardia versus fibrillation.
    Agarwal JB; Naccarella FF; Weintraub WS; Helfant RH
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1601-7. PubMed ID: 4003304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A; Di Pede F; Delise P; Piccolo E
    G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propafenone treatment of recurrent ventricular tachycardia: comparison of continuous electrocardiographic recording and electrophysiologic study in predicting drug efficacy.
    Heger JJ; Hubbard J; Zipes DP; Miles WM; Prystowsky EN
    Am J Cardiol; 1984 Nov; 54(9):40D-44D. PubMed ID: 6496368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiologic evaluation of antiarrhythmic therapy for ventricular tachyarrhythmias.
    Kuchar DL; Garan H; Ruskin JN
    Am J Cardiol; 1988 Oct; 62(12):39H-45H. PubMed ID: 3052008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is a baseline electrophysiologic study mandatory for the management of patients with spontaneous, sustained, ventricular tachyarrhythmias?
    Mitchell LB; Gettes LS
    Prog Cardiovasc Dis; 1996; 38(5):385-92. PubMed ID: 8604443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
    Kim SG; Felder SD; Waspe LE; Fisher JD
    Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.